Biotech Showcase

January 13–15, 2025
San Francisco, CA

Kimberly Ha
CEO and Founder at KKH Advisors


Kimberly is Founder and CEO of KKH Advisors, a life sciences and digital health strategic communications firm. She was previously Senior Director at FTI Consulting, Life Sciences and Healthcare, Capital Markets, where she advised a broad range of clients from Fortune 500 to early-stage companies on business transformation, corporate and executive positioning, crisis and issues management, and financial communications with a focus on IPO readiness.

Prior to FTI Consulting (NYSE: FCN), a global business advisory firm, she was Global Editor at BioPharm Insight, a business intelligence product launched by the Financial Times Group. She started her career as an M&A reporter in Hong Kong covering Asia-Pacific healthcare, and transferred to New York to cover US pharmaceuticals in 2007.

She is a guest lecturer at Columbia University and Georgetown University on change management communications and a guest speaker at Weill Cornell Medicine Bioventure eLab. Kimberly is a Board Member for the Galien Foundation and a Limited Partner at Array Ventures, a SF-based deeptech VC fund. She has a BA in Psychology from New York University.

Agenda Sessions

  • Getting Noticed in the Current Financial Digimed Landscape

  • Biotech Funding: Times are Tough, Will it Get Better in 2024?